Skip to content

Effects of dexmedetomidine nasal spray on preoperative anxiety status in patients with breast or thyroid cancer anxiety: a multicenter randomized, double-blind, placebo-controlled clinical trial

Effects of dexmedetomidine nasal spray on preoperative anxiety status in patients with breast or thyroid cancer anxiety: a multicenter randomized, double-blind, placebo-controlled clinical trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080755
Enrollment
Unknown
Registered
2024-02-06
Start date
2024-02-20
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anxiety

Interventions

Dexmedetomidine nasal spray group:Use dexmedetomidine nasal spray before going to sleep the night before surgery.
Saline nasal spray group:Use saline nasal spray before going to sleep the night before surgery.

Sponsors

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: (1) Patients aged 18-65, both male and female; (2) Scheduled for breast cancer resection or thyroid cancer resection; (3) Voluntarily participate in this clinical trial, and willingly sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Amsterdam Anxiety Scale score 2 times the upper limit of normal, or total bilirubin >1.5 times the upper limit of normal; (12) Abnormal renal function: participants with screening creatinine >1.5 times the upper limit of normal; (13) Participants allergic to the drug components or ingredients used in this study, such as dexmedetomidine, propofol, opioids, etc.; (14) Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
State anxiety inventory;

Secondary

MeasureTime frame
Perioperative sleep quality;numerical rating scale;The incidence of postoperative nausea and vomiting;Postoperative recovery quality;Perioperative complications;

Countries

China

Contacts

Public ContactBin Jia

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

jiabin_11@163.com+86 137 6078 4739

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026